References
- Report of the First Meeting of the WHO Alliance for the Global Elimination of Trachoma. Geneva: World Health Organization, 1997. (Unpublished document WHO/PBUGET/97.1).
- Dawson C, Schachter J. Can blinding trachoma be eliminated worldwide? Arch Ophthalmol. 1999;117(7):974.
- Limburg H, Bah M, Johnson GI Trial of the Trachoma Rapid Assessment methodology in The Gambia. Ophthalmic Epidemiol. 2001;8(2-3):73–85.
- Frick KD, West SK. The SAFE strategy for trachoma control: Planning a cost-effectiveness analysis of the antibiotic component and beyond. Ophthalmic Epidemiol. 2001;8(4):205–214.
- Frick KD, Keuffel E, Bowman RJC. Epidemiological, demographic, and economic analyses: Measurement of the value of trichiasis surgery in the Gambia. Ophthalmic Epidemiol. 2001;8(2-3):191–201.
- Frick KD, Lietman TM, Osaki Holm S, et al. Cost-effectiveness of trachoma control measures: comparing targeted household treatment and mass treatment of children. Bull WHO. 2001;79(3): 201–207.
- Bowman RI Sillah A, Van Dehn C, et al. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci. 2000;41(13): 4074–4079.
- Evans TG, Ranson MK, Kyaw TA, Ko CK. Cost effectiveness and cost utility of preventing trachomatous visual impairment: Lessons from 30 years of trachoma control in Burma. Br J Ophthalmol. 1996;80(10): 88o-889.
- Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull WHO. 1995;73(0:115–121.
- Murray CJL, Lopez AD, editors. The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1–990 and projected to 2020. Cambridge, MA: Harvard School of Public Health on behalf of the World Health Organization and the World Bank, 1996.
- Ranson MK, Evans TG. The global burden of trachomatous visual impairment: I. Assessing prevalence. Int Ophthalmol. 1995–96;19(5): 261–270.
- Evans T, Ranson MK. The global burden of trachomatous visual impairment: II. Assessing burden. Int Ophthalmol. I995-96;19(5):271–280.
- Mansour AM, Kassak K, Chaya M, et al. National survey of blindness and low vision in Lebanon. Br J Ophthalmol. I997;81(10):905–906.
- Newland HS, Woodward AI Taumoepeau LA, et al. Epidemiology of blindness and visual impairment in the kingdom of Tonga. Br J Ophthalmol. 1994;78(5): 344–348.
- Schwartz EC, Huss R, Hopkins A, et al. Blindness and visual impairment in a region endemic for onchocerciasis in the Central African Republic. Br J Ophthalmol. 1997;81 (6):443–447.
- Al Faran ME Low prevalence of trachoma in the south western part of Saudi Arabia, results of a population based study. Int Ophthalmol. I 994–95; I 8(6):379–382.
- Negrel AD, Minassian DC, Sayek E Blindness and low vision in southeast Turkey. Ophthalmic Epidemiol. I 996;3(3):127–134.
- Future Approaches to Trachoma Control: Report of a Global Scientific Meeting. Geneva, 17–20 June 1996. (unpublished document WHO/PBL/96/56).
- Taylor HR, Velasco FM, Sommer A. The ecology of trachoma: An epidemiological study in southern Mexico. Bull WHO. 1985;63(3): 559–567.
- Luna EJ, Medina NH, Oliveira MB, et al. Epidemiology of trachoma in Bebedouro State of Sao Paulo, Brazil: Prevalence and risk factors. Mt J Epidemiol. 1992;21 (I): 169–177.
- United Nations Population Division, Department of Economic and Social Affairs. World Population Prospects: The 1998 Revision. Vol. I: Comprehensive Tables;E.99.XIII.9; 1998.
- Koopmanschap MA, Rutten FF, Van Ineveld BM, Van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ. 1995;14.(2):171–189.
- Frick KD, Melia BM, Buhrmann RR, West SK. Trichiasis and disability in a Trachoma Endemic Area of Tanzania. Arch Ophthalmol. 2001;I19(12):1839–1844.
- Smith AF, Smith JG. The economic burden of global blindness: A price too high! Br J Ophthalmol. 1996; 80(4):276–277.
- Shamanna BR, Dandona L, Rao GN. Economic burden of blindness in India. Indian J Ophthalmol. 1998; 46(3):169–172.
- Over M, Bertozzi S, Chin J. Guidelines for rapid estimation of the direct and indirect costs of HIV infection in a developing country. Health Policy. 1989;I I (2):169–186.
- World Development Indicators 2000. Washington DC: World Bank, 2000.
- The World Health Report 2000. Health Systems: Improving Performance. Geneva: World Health Organization, 2000.
- Williams A. Calculating the global burden of disease: Time for a strategic reappraisal? Health Econ. 1999;8(0a–8.
- Mabey D, Bailey R. Eradication of trachoma worldwide. Br J Ophthalmol. 1999;83 (II):1261–1263.
- Mackey R. The way we live now: Salient facts: Global health campaigns; ten diseases on the way out. New York Times. May 6,2001.
- Resnikoff S, Pararajasegaram R. Blindness prevention programmes: Past, present, and future. Bull WHO. 2001;79(3):222–226.
- Christian P, West KP, Jr, Khatry SK, et al. Night blindness during pregnancy and subsequent mortality among women in Nepal: Effects of vitamin A and beta-carotene supplementation. Am J Epidemiol. 2000;152(454.2–54.7.
- Courtright P, Kim SH, Lee HS, Lewallen S. Excess mortality associated with blindness in leprosy patients in Korea. Lepr Rev. 1997; 68(4):326–330.
- Kirkwood B, Smith P, Marshall T, Prost A. Relationships between mortality, visual acuity and microfilarial load in the area of the Onchocerciasis Control Programme. Trans R Soc Trop Med Hyg. 1983; 77(6):862–868.